Vericel Corporation is the leader in developing patient-specific, expanded multicellular therapies for use in the treatment of patients with severe, chronic cardiovascular diseases. The company's proprietary cell-processing technology enables the manufacture of ixmyelocel-T, a patient-specific multicellular therapy expanded from a patient's own bone marrow and delivered directly to damaged tissues.
Company Website: http://www.aastrom.com/
Vericel Corporation (NASDAQ: VCEL) Stock Message Board
3 | ASTM Stock Charts Last: UNCH Thursday, February | chartguy89 | 02/27/2014 2:06:57 PM |
2 | ASTM. $0.77 new volume breakout | PoemStone | 08/05/2013 9:21:03 PM |
1 | Looks like a Runner. | ronb | 08/05/2013 6:10:44 PM |